Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)33391-1
Abstract: Rivaroxaban is an oral direct Factor Xa inhibitor widely used for stroke prevention in patients with non-valvular atrial fibrillation. It is convenient to use since it does not require monitoring of its level. However, hemorrhage…
read more here.
Keywords:
rivaroxaban use;
associated rivaroxaban;
hemorrhagic tamponade;
spontaneous hemorrhagic ... See more keywords